These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25655032)

  • 1. Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads.
    Salvat RS; Choi Y; Bishop A; Bailey-Kellogg C; Griswold KE
    Biotechnol Bioeng; 2015 Jul; 112(7):1306-18. PubMed ID: 25655032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computationally driven deletion of broadly distributed T cell epitopes in a biotherapeutic candidate.
    Salvat RS; Parker AS; Guilliams A; Choi Y; Bailey-Kellogg C; Griswold KE
    Cell Mol Life Sci; 2014 Dec; 71(24):4869-80. PubMed ID: 24880662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpiSweep: Computationally Driven Reengineering of Therapeutic Proteins to Reduce Immunogenicity While Maintaining Function.
    Choi Y; Verma D; Griswold KE; Bailey-Kellogg C
    Methods Mol Biol; 2017; 1529():375-398. PubMed ID: 27914063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-guided deimmunization of therapeutic proteins.
    Parker AS; Choi Y; Griswold KE; Bailey-Kellogg C
    J Comput Biol; 2013 Feb; 20(2):152-65. PubMed ID: 23384000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and analysis of immune-evading enzymes for ADEPT therapy.
    Osipovitch DC; Parker AS; Makokha CD; Desrosiers J; Kett WC; Moise L; Bailey-Kellogg C; Griswold KE
    Protein Eng Des Sel; 2012 Oct; 25(10):613-23. PubMed ID: 22898588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization algorithms for functional deimmunization of therapeutic proteins.
    Parker AS; Zheng W; Griswold KE; Bailey-Kellogg C
    BMC Bioinformatics; 2010 Apr; 11():180. PubMed ID: 20380721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computationally optimized deimmunization libraries yield highly mutated enzymes with low immunogenicity and enhanced activity.
    Salvat RS; Verma D; Parker AS; Kirsch JR; Brooks SA; Bailey-Kellogg C; Griswold KE
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5085-E5093. PubMed ID: 28607051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the Pareto optimal design space for a functionally deimmunized biotherapeutic candidate.
    Salvat RS; Parker AS; Choi Y; Bailey-Kellogg C; Griswold KE
    PLoS Comput Biol; 2015 Jan; 11(1):e1003988. PubMed ID: 25568954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Deimmunization of Interferon Beta-1b by Identifying and Silencing Human T Cells Epitopes.
    Moradi Hasan-Abad A; Adabi E; Sadroddiny E; Khorramizadeh MR; Mazlomi MA; Mehravar S; Kardar GA
    Iran J Allergy Asthma Immunol; 2019 Aug; 18(4):427-440. PubMed ID: 31522451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHCEpitopeEnergy, a Flexible Rosetta-Based Biotherapeutic Deimmunization Platform.
    Yachnin BJ; Mulligan VK; Khare SD; Bailey-Kellogg C
    J Chem Inf Model; 2021 May; 61(5):2368-2382. PubMed ID: 33900750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions.
    Kumar S; Singh SK; Wang X; Rup B; Gill D
    Pharm Res; 2011 May; 28(5):949-61. PubMed ID: 21437790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deimmunization of protein therapeutics - Recent advances in experimental and computational epitope prediction and deletion.
    Zinsli LV; Stierlin N; Loessner MJ; Schmelcher M
    Comput Struct Biotechnol J; 2021; 19():315-329. PubMed ID: 33425259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic protein deimmunization by T-cell epitope removal: antigen-specific immune responses in vitro and in vivo.
    Asgari S; Ebrahim-Habibi A; Mahdavi M; Choopani M; Mirzahoseini H
    APMIS; 2017 Jun; 125(6):544-552. PubMed ID: 28418077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift.
    Cantor JR; Yoo TH; Dixit A; Iverson BL; Forsthuber TG; Georgiou G
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1272-7. PubMed ID: 21209329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removing T-cell epitopes with computational protein design.
    King C; Garza EN; Mazor R; Linehan JL; Pastan I; Pepper M; Baker D
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8577-82. PubMed ID: 24843166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of therapeutic proteins to delete T-cell epitopes while maintaining beneficial residue interactions.
    Parker AS; Griswold KE; Bailey-Kellogg C
    J Bioinform Comput Biol; 2011 Apr; 9(2):207-29. PubMed ID: 21523929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of available design space for identification of non-immunogenic protein therapeutics.
    Lee SC
    Biomed Microdevices; 2010 Apr; 12(2):283-6. PubMed ID: 20012559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity.
    Dhanda SK; Grifoni A; Pham J; Vaughan K; Sidney J; Peters B; Sette A
    Immunology; 2018 Jan; 153(1):118-132. PubMed ID: 28833085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens.
    Nosrati M; Mohabatkar H; Behbahani M
    Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape and selection of vaccine epitopes in SARS-CoV-2.
    Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.